437 related articles for article (PubMed ID: 26038004)
1. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
Akahoshi T; Sugimori H; Kaku N; Tokuda K; Nagata T; Noda E; Morita M; Hashizume M; Maehara Y
Eur J Trauma Emerg Surg; 2015 Oct; 41(5):531-8. PubMed ID: 26038004
[TBL] [Abstract][Full Text] [Related]
2. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.
Ookura M; Hosono N; Tasaki T; Oiwa K; Fujita K; Ito K; Lee S; Matsuda Y; Morita M; Tai K; Negoro E; Kishi S; Iwasaki H; Ueda T; Yamauchi T
Medicine (Baltimore); 2018 Nov; 97(44):e12981. PubMed ID: 30383650
[TBL] [Abstract][Full Text] [Related]
4. Impact of Recombinant Human Soluble Thrombomodulin for Disseminated Intravascular Coagulation.
Itoh S; Shirabe K; Kohnoe S; Sadanaga N; Kajiyama K; Yamagata M; Anai H; Harimoto N; Ikegami T; Yoshizumi T; Maehara Y
Anticancer Res; 2016 May; 36(5):2493-6. PubMed ID: 27127163
[TBL] [Abstract][Full Text] [Related]
5. Recombinant soluble thrombomodulin for postoperative disseminated intravascular coagulation.
Hashimoto D; Chikamoto A; Miyanari N; Ohara C; Kuramoto M; Horino K; Ohshima H; Baba H
J Surg Res; 2015 Aug; 197(2):405-11. PubMed ID: 25972310
[TBL] [Abstract][Full Text] [Related]
6. Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis.
Ogura T; Eguchi T; Amano M; Sano T; Nishioka N; Miyano A; Tsujimae M; Tanimura H; Yamada T; Terashima Y; Okada A; Higuchi K
Thromb Res; 2019 Apr; 176():74-78. PubMed ID: 30780007
[TBL] [Abstract][Full Text] [Related]
7. Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis.
Okuda A; Ogura T; Imanishi M; Miyano A; Nishioka N; Higuchi K
Gut Liver; 2018 Jul; 12(4):471-477. PubMed ID: 29699063
[TBL] [Abstract][Full Text] [Related]
8. Effect of Recombinant Human Soluble Thrombomodulin on Coagulation-Related Variables in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Retrospective Observational Study.
Mitaka C; Kawagoe I; Satoh D; Hayashida M
Clin Appl Thromb Hemost; 2021; 27():10760296211050356. PubMed ID: 34859680
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation.
Morita N; Nakahara K; Morita R; Suetani K; Michikawa Y; Sato J; Tsuji K; Ikeda H; Matsunaga K; Watanabe T; Matsumoto N; Okuse C; Suzuki M; Itoh F
Intern Med; 2019 Apr; 58(7):907-914. PubMed ID: 30449812
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of Recombinant Thrombomodulin for Sepsis-Associated Disseminated Intravascular Coagulation Caused by Urinary Tract Infections].
Tachibana A; Iida K; Itami Y; Hashimura M; Toyoshima Y; Hosokawa Y; Fujimoto K
Hinyokika Kiyo; 2023 Nov; 69(11):309-314. PubMed ID: 38031329
[TBL] [Abstract][Full Text] [Related]
11. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation.
Suetani K; Okuse C; Nakahara K; Michikawa Y; Noguchi Y; Suzuki M; Morita R; Sato N; Kato M; Itoh F
World J Gastroenterol; 2015 Jan; 21(2):533-40. PubMed ID: 25593469
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
[TBL] [Abstract][Full Text] [Related]
13. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
[TBL] [Abstract][Full Text] [Related]
14. Assessment of bleeding in patients with disseminated intravascular coagulation after receiving surgery and recombinant human soluble thrombomodulin: A cohort study using a database.
Yamaguchi T; Kitajima Y; Miyauchi Y; Izawa K; Tanaka M; Hirata M; Sadatsuki Y; Ogawa Y
PLoS One; 2018; 13(10):e0205146. PubMed ID: 30296304
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant Therapy for Disseminated Intravascular Coagulation After Gastrointestinal Surgery.
Hashimoto D; Okawa T; Maruyama R; Matsumura F; Shibata Y; Kohrogi H
Anticancer Res; 2019 Jan; 39(1):25-31. PubMed ID: 30591437
[TBL] [Abstract][Full Text] [Related]
16. Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases.
Kawano N; Tasaki A; Kuriyama T; Tahara Y; Yoshida S; Ono N; Himeji D; Yamashita K; Shibata Y; Goto T; Inoue T; Yokota-Ikeda N; Uezono S; Yuge A; Nishiguchi T; Kinjo T; Ogura Y; Beppu K; Ueda Y; Kinoshita M; Moritake H; Shimoda K; Ochiai H; Ueda A
Intern Med; 2014; 53(3):205-13. PubMed ID: 24492688
[TBL] [Abstract][Full Text] [Related]
17. [Treatment with recombinant thrombomodulin on disseminated intravascular coagulation caused by urinary tract infections; a retrospective comparative study with control cases].
Machioka K; Shigehara K; Kadomoto S; Iwamoto H; Miyagi T; Nakashima T; Namiki M
Hinyokika Kiyo; 2015 Jan; 61(1):1-6. PubMed ID: 25656012
[TBL] [Abstract][Full Text] [Related]
18. [The efficacy of early use of recombinant soluble thrombomodulin for disseminated intravascular coagulation complicated with hematologic malignancies].
Usami M; Kuroda H; Yoshida M; Sakamoto H; Shimoyama S; Kanari Y; Yamada M; Abe T; Fujii S; Maeda M
Rinsho Ketsueki; 2015 Jun; 56(6):673-80. PubMed ID: 26256878
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of recombinant human soluble thrombomodulin in severe postpartum hemorrhage with disseminated intravascular coagulation.
Sugawara J; Suenaga K; Hoshiai T; Sato T; Nishigori H; Nagase S; Yaegashi N
Clin Appl Thromb Hemost; 2013 Sep; 19(5):557-61. PubMed ID: 22496090
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors.
Ouchi K; Takahashi S; Chikamatsu S; Ito S; Takahashi Y; Kawai S; Okita A; Kasahara Y; Okada Y; Imai H; Komine K; Saijo K; Takahashi M; Shirota H; Takahashi M; Gamoh M; Ishioka C
Int J Clin Oncol; 2018 Aug; 23(4):790-798. PubMed ID: 29511940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
